tiprankstipranks
Trending News
More News >
Oncotelic Therapeutics (OTLC)
OTHER OTC:OTLC
US Market

Oncotelic Therapeutics (OTLC) Technical Analysis

Compare
86 Followers

Technical Sentiment

Overall Consensus
Strong Sell
4Bullish
3Neutral
15Bearish
Technical Analysis Consensus
Sell
3Bullish
3Neutral
4Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Oncotelic Therapeutics’s (OTLC) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Oncotelic Therapeutics is a Sell.
Oncotelic Therapeutics’s (OTLC) 20-Day exponential moving average is 0.05, while Oncotelic Therapeutics’s (OTLC) share price is <$0.1, making it a Sell.
Oncotelic Therapeutics’s (OTLC) 50-Day exponential moving average is 0.06, while Oncotelic Therapeutics’s (OTLC) share price is <$0.1, making it a Sell.

Oncotelic Therapeutics (OTLC) Pivot Points

Mar 10, 2026, 07:45 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.04
0.04
0.04
0.04
0.04
0.04
0.04
Fibonacci
0.04
0.04
0.04
0.04
0.04
0.04
0.04
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Oncotelic Therapeutics (OTLC) Moving Averages

Mar 10, 2026, 07:45 AM
Period
Simple
Exponential
MA5
0.04Buy
0.04Sell
MA10
0.04Sell
0.04Sell
MA20
0.05Sell
0.05Sell
MA50
0.07Sell
0.06Sell
MA100
0.08Sell
0.07Sell
MA200
0.07Sell
0.06Sell
Oncotelic Therapeutics’s (OTLC) 10-Day exponential moving average is 0.04, while Oncotelic Therapeutics’s (OTLC) share price is <$0.1, making it a Sell.
Oncotelic Therapeutics’s (OTLC) 100-Day exponential moving average is 0.07, while Oncotelic Therapeutics’s (OTLC) share price is <$0.1, making it a Sell.
Oncotelic Therapeutics’s (OTLC) stock price is <$0.1 and Oncotelic Therapeutics’s (OTLC) 50-day simple moving average is 0.07, creating a Sell signal.
Oncotelic Therapeutics’s (OTLC) stock price is <$0.1 and Oncotelic Therapeutics’s (OTLC) 100-day simple moving average is 0.08, creating a Sell signal.
Oncotelic Therapeutics’s (OTLC) stock price is <$0.1 and Oncotelic Therapeutics’s (OTLC) 200-day simple moving average is 0.07, creating a Sell signal.

Oncotelic Therapeutics (OTLC) Technical Indicators

Mar 10, 2026, 07:45 AM
Name
Value
Implied Action
RSI (14)
37.73
Neutral
STOCH (9,6)
-7.87
Buy
STOCHRSI (14)
-5.81
Buy
MACD (12,26)
>-0.01
Sell
ADX (14)
48.49
Neutral
Williams %R
-100.00
Buy
CCI (14)
-81.09
Neutral
ATR (14)
<0.01
-
Ultimate Oscillator
23.94
Sell
ROC
-20.00
Sell
Oncotelic Therapeutics’s (OTLC) Relative Strength Index (RSI) is 37.73, creating a Neutral signal.
Oncotelic Therapeutics’s (OTLC) Trend Strength Indicator (ADX) is 48.49, creating a Neutral signal.
Oncotelic Therapeutics’s (OTLC) Commodity Channel Index (CCI) is -81.09, creating a Neutral signal.
Oncotelic Therapeutics’s (OTLC) Price Rate of Change (ROC) is -20.00, creating a Sell signal.

FAQ

Is OTLC a Buy, Hold, or Sell?
Based on OTLC’s technical indicators, OTLC is a Strong Sell.
    What is OTLC’s RSI (14)?
    OTLC’s RSI (14) is 37.73, which suggests OTLC is a Neutral.
      What is OTLC’s MACD?
      OTLC’s MACD is >-0.01, which suggests OTLC is a Sell.
        What is OTLC’s 5-day moving average?
        OTLC’s 5-day moving average is 0.04, which suggests OTLC is a Buy.
          What is OTLC’s 20-day moving average?
          OTLC 20-day moving average is 0.05, which suggests OTLC is a Sell.
            What is OTLC’s 50-day moving average?
            OTLC’s 50-day moving average is 0.07, which suggests OTLC is a Sell.
              What is OTLC’s 200-day moving average?
              OTLC’s 200-day moving average is 0.07, which suggests OTLC is a Sell.
                What is OTLC’s Williams % R (14)?
                OTLC’s Williams % R (14) is -100.00, which suggests OTLC is a Buy.
                  What is OTLC’s CCI (14)?
                  OTLC’s CCI (14) is -81.09, which suggests OTLC is a Neutral.